A comparative study of the gut microbiota in immune-mediated inflammatory diseases—does a common dysbiosis exist?
Background Immune-mediated inflammatory disease (IMID) represents a substantial health concern. It is widely recognized that IMID patients are at a higher risk for developing secondary inflammation-related conditions. While an ambiguous etiology is common to all IMIDs, in recent years, considerable...
Saved in:
Published in | Microbiome Vol. 6; no. 1; pp. 221 - 15 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
13.12.2018
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 2049-2618 2049-2618 |
DOI | 10.1186/s40168-018-0603-4 |
Cover
Loading…
Summary: | Background
Immune-mediated inflammatory disease (IMID) represents a substantial health concern. It is widely recognized that IMID patients are at a higher risk for developing secondary inflammation-related conditions. While an ambiguous etiology is common to all IMIDs, in recent years, considerable knowledge has emerged regarding the plausible role of the gut microbiome in IMIDs. This study used 16S rRNA gene amplicon sequencing to compare the gut microbiota of patients with Crohn’s disease (CD;
N
= 20), ulcerative colitis (UC;
N
= 19), multiple sclerosis (MS; N = 19), and rheumatoid arthritis (RA;
N
= 21) versus healthy controls (HC;
N
= 23). Biological replicates were collected from participants within a 2-month interval. This study aimed to identify common (or unique) taxonomic biomarkers of IMIDs using both differential abundance testing and a machine learning approach.
Results
Significant microbial community differences between cohorts were observed (pseudo
F
= 4.56;
p
= 0.01). Richness and diversity were significantly different between cohorts (pFDR < 0.001) and were lowest in CD while highest in HC. Abundances of
Actinomyces
,
Eggerthella, Clostridium III
,
Faecalicoccus
, and
Streptococcus
(pFDR < 0.001) were significantly higher in all disease cohorts relative to HC, whereas significantly lower abundances were observed for
Gemmiger
,
Lachnospira
, and
Sporobacter
(pFDR < 0.001). Several taxa were found to be differentially abundant in IMIDs versus HC including significantly higher abundances of
Intestinibacter
in CD,
Bifidobacterium
in UC, and unclassified
Erysipelotrichaceae
in MS and significantly lower abundances of
Coprococcus
in CD,
Dialister
in MS, and
Roseburia
in RA. A machine learning approach to classify disease versus HC was highest for CD (AUC = 0.93 and AUC = 0.95 for OTU and genus features, respectively) followed by MS, RA, and UC.
Gemmiger
and
Faecalicoccus
were identified as important features for classification of subjects to CD and HC. In general, features identified by differential abundance testing were consistent with machine learning feature importance.
Conclusions
This study identified several gut microbial taxa with differential abundance patterns common to IMIDs. We also found differentially abundant taxa between IMIDs. These taxa may serve as biomarkers for the detection and diagnosis of IMIDs and suggest there may be a common component to IMID etiology. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
ISSN: | 2049-2618 2049-2618 |
DOI: | 10.1186/s40168-018-0603-4 |